- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05994833
Virtual Physical Therapy Support for Runners
September 14, 2023 updated by: University of Florida
Virtual Physical Therapy Support for Runners Receiving Gait Analyses for Lower Body Running Related Musculoskeletal Issues
This study will compare standard of care of home exercise for running rehabilitation to the combined treatment of home exercise with an individually provided four-session virtual physical therapy support program intervention on pain and physical function movements (controlled dual and single leg squat and lateral hopping in individuals post running injury.
These collective findings will help provide new evidence of the responses to an individually provided virtual PT interventions among runners.
Study Overview
Study Type
Interventional
Enrollment (Estimated)
85
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sharareh PhD, PT
- Phone Number: 3522738453
- Email: sharareh75@ufl.edu
Study Contact Backup
- Name: Jamie Bolliong
- Phone Number: 3522737412
- Email: jamiekbolling@ufl.edu
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32607
- Recruiting
- University of Florida College of medicine- Dept of PM&R
-
Contact:
- Sharareh Sharififar, PhD, PT
- Phone Number: 352-273-8453
- Email: sharareh75@ufl.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Age of 18 to 65 years
- Regularly running at least 12 miles a week prior to development of musculoskeletal complaint.
- Free of surgical history of surgery to either lower limb
- No history of major bony injury to the lower limb such as traumatic fracture, within the past 12 months
- Presence of chronic lower body running related injuries (e.g., patellofemoral pain, IT band syndrome, Achilles tendinitis, chronic lower back pain after running)
- Body mass index (BMI) <=35 kg/m2
Exclusion Criteria:
- Pregnant women
- < 18 or 65 years
- BMI >35 kg/m2
- Mental disablement (down's syndrome or dementia)
- Any persons incarcerated, on parole, on probation, or awaiting trial.
- Individuals with neurologic or degenerative musculoskeletal disease, such as rheumatoid arthritis, muscular dystrophy, or Parkinson's disease.
- Current acute running related or sport related injury (e.g., ankle sprain, hip labral tear, ACL strain during an event or run)
- Individuals with a history of strong risk factors for poor fracture healing, such as uncontrolled diabetes, chemotherapy, end-stage organ disease, dialysis or smoking
- Unwilling to forgo your potential in-person therapy visits for a month after enrollment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: paper-based standard care exercise program
|
|
Experimental: VPT
|
The VPT will be comprised of weekly virtual visits with the participant for one month.
During the visits, the physical therapist will review the exercises that were prescribed, adherence, provide feedback to the participant as they execute the exercises onscreen and make corrections, make any progression or adjustments to the exercises, review running cues they learned from the testing session and answer any questions.
The therapist will also review any new activities that are initiated during the previous week (to control for confounders), changes in musculoskeletal pain and participation in running volume.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline numerical rating scale for pain (NRSpain) at 4 weeks
Time Frame: Visits 6; one month post enrollment
|
A numerical rating scale for pain (NRSpain) will be used to assess changes in lower body related musculoskeletal pain at rest (now, average over the last week) and during weight bearing activity (like walking) on a range of lowest score of 0 (no pain) to 10 (worst pain)
|
Visits 6; one month post enrollment
|
Change from baseline numerical rating scale for pain (NRSpain) at 6 months
Time Frame: Visits 7; six months post enrollment
|
A numerical rating scale for pain (NRSpain) will be used to assess changes in lower body related musculoskeletal pain at rest (now, average over the last week) and during weight bearing activity (like walking) on a range of lowest score of 0 (no pain) to 10 (worst pain)
|
Visits 7; six months post enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline squat quality on single leg (using dominant leg) at 4 weeks
Time Frame: visit 6; one month post enrollment
|
Squat performance on the single leg (using dominant leg) will be scored on a range of scale 1 (best performance) to 3 (worst performance)
|
visit 6; one month post enrollment
|
Change from baseline squat quality on single leg (using dominant leg) at 6 months
Time Frame: visit 7; six months post enrollment
|
Squat performance on the single leg (using dominant leg) will be scored on a range of scale 1 (best performance) to 3 (worst performance)
|
visit 7; six months post enrollment
|
Change from baseline squat quality on the dual leg at 4 weeks
Time Frame: visit 6; one month post enrollment
|
Squat performance on the dual leg will be scored on a range of scale 1 (best performance) to 3 (worst performance)
|
visit 6; one month post enrollment
|
Change from baseline squat quality on the dual leg at 6 months
Time Frame: visit 7; six months post enrollment
|
Squat performance on the dual leg will be scored on a range of scale 1 (best performance) to 3 (worst performance)
|
visit 7; six months post enrollment
|
Change from baseline standing stork quality (using dominant leg) at 4 weeks
Time Frame: visit 6; one month post enrollment
|
Balance performance on the standing stork will be scored on the ranges of excellent to poor scale compared to the normative data published for males/females (Schell & Leelarthaepin 1994)
|
visit 6; one month post enrollment
|
Change from baseline standing stork quality (using dominant leg) at 6 months
Time Frame: visit 7; six months post enrollment
|
Balance performance on the standing stork will be scored on the ranges of excellent to poor scale compared to the normative data published for males/females (Schell & Leelarthaepin 1994)
|
visit 7; six months post enrollment
|
Change from baseline displacement in forward-backward direction during 20 sec of static standing position at 4 weeks
Time Frame: visit 6; one month post enrollment
|
A markerless motion system will be used.
Cameras will be used to collect the backward-forward displacement during 20 sec of static standing on both legs will be analyzed for ability to control static balance.
|
visit 6; one month post enrollment
|
Change from baseline displacement in forward-backward direction during 20 sec of static standing position at 6 months
Time Frame: visit 7; six months post enrollment
|
A markerless motion system will be used.
Cameras will be used to collect the backward-forward displacement during 20 sec of static standing on both legs will be analyzed for ability to control static balance.
|
visit 7; six months post enrollment
|
Change from baseline gait speed at 4 weeks
Time Frame: visit 6; one month post enrollment
|
Spatiotemporal parameters are analyzed [i.e.
gait speed (meters/sec), cadence (steps/minute)]
|
visit 6; one month post enrollment
|
Change from baseline gait speed at 6 months
Time Frame: visit 7; six months post enrollment
|
Spatiotemporal parameters are analyzed [i.e.
gait speed (meters/sec), cadence (steps/minute)]
|
visit 7; six months post enrollment
|
Change from baseline displacement of the center of gravity in vertical direction at 4 weeks
Time Frame: visit 6; one month post enrollment
|
Spatiotemporal parameters are analyzed (i.e.
center of gravity vertical displacement measured in centimeters)
|
visit 6; one month post enrollment
|
Change from baseline displacement of the body in vertical direction at 6 months
Time Frame: visit 7; six months post enrollment
|
Spatiotemporal parameters are analyzed (i.e.
center of gravity vertical displacement measured in centimeters)
|
visit 7; six months post enrollment
|
Change from baseline displacement between strides at 4 weeks
Time Frame: visit 6; one month post enrollment
|
Spatiotemporal parameters are analyzed (i.e.
stride width measured in centimeters)
|
visit 6; one month post enrollment
|
Change from baseline displacement between strides at 6 months
Time Frame: visit 7; six months post enrollment
|
Spatiotemporal parameters are analyzed (i.e.
stride width measured in centimeters)
|
visit 7; six months post enrollment
|
Change from baseline hopping quality (using dominant leg) at 4 weeks
Time Frame: visit 6; one month post enrollment
|
Quality performance on the hopping three times (using dominant leg) and land on the same limb as far as possible will be scored based on the distance hopped, measured at the level of the great toe on a range of scale 1 (best performance) to 3 (worst performance)
|
visit 6; one month post enrollment
|
Change from baseline hopping quality (using dominant leg) at 6 months
Time Frame: visit 7; six months post enrollment
|
Quality performance on the hopping three times (using dominant leg) and land on the same limb as far as possible will be scored based on the distance hopped, measured at the level of the great toe on a range of scale 1 (best performance) to 3 (worst performance)
|
visit 7; six months post enrollment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sharareh Sharififar, PhD, PT, University of Florida
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 10, 2023
Primary Completion (Estimated)
August 1, 2025
Study Completion (Estimated)
June 1, 2030
Study Registration Dates
First Submitted
June 12, 2023
First Submitted That Met QC Criteria
August 9, 2023
First Posted (Actual)
August 16, 2023
Study Record Updates
Last Update Posted (Actual)
September 18, 2023
Last Update Submitted That Met QC Criteria
September 14, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- IRB202301005
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Musculoskeletal Complication
-
Children's Hospital Medical Center, CincinnatiCompletedHealthy Volunteers | Musculoskeletal ComplicationUnited States
-
University of ValenciaUnknownBone Resorption | Implant ComplicationSpain
-
Azienda Ospedaliera S. Maria della MisericordiaCompletedMechanical Ventilation ComplicationItaly
-
University of MalagaCompletedMusculoskeletal Diseases | Complication of Manipulation Procedure | Defective; Learning (Specific)Spain
-
University of British ColumbiaCompletedOsteoarthritis, Hip | Complication of Surgical Procedure | Arthroplasty Complications | Perioperative ComplicationCanada
-
Henan Cancer HospitalNot yet recruiting
-
University Hospital Inselspital, BerneTerminated
-
University of LiegeCompletedKnee Osteoarthritis | Arthroplasty Complications | Sedation Complication | Anesthesia Complication | Hypnotic; Anxiety DisorderBelgium
-
Reinier Haga Orthopedisch CentrumCompletedComplication of Surgical Procedure | Arthropathy of KneeNetherlands
-
Asst Melegnano e MartesanaEnrolling by invitationMortality | Nephrotoxicity | Respiratory Complication | Neurological Complication | Surgical Complication | Metabolic Complication | Cardiovascular ComplicationItaly
Clinical Trials on VPT
-
Minia UniversityNot yet recruiting
-
Johns Hopkins UniversityWalter Reed National Military Medical Center; Fort Belvoir Community Hospital; Neuroscience Research AustraliaRecruitingMild Traumatic Brain Injury | Vestibular NeuropathyUnited States
-
Sohag UniversityRecruitingAuditory Neuropathy Spectrum Disorder,, Peripheral NeuropathyEgypt
-
Aalborg University HospitalAalborg UniversityEnrolling by invitationDiabetes | Diabetes Mellitus, Type 1 | Diabetic Neuropathy Peripheral | Small Fiber NeuropathyDenmark